← Leaderboards
Courtney Fitzhugh
National Heart, Lung, And Blood Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Heart, Lung, And Blood Institute
Same institution · by research overlap
Others in their field
Top investigators on “Protocols Documentation”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$562,015,656
- Lawrence Corey · Fred Hutchinson Cancer Center$498,533,651
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Judith S. Currier · University Of California Los Angeles$445,196,577
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$381,639,813
Research focus
Protocols DocumentationDoseAcuteSickle Cell AnemiaMorbidity - Disease RateBaseHemoglobinMortalityEnd Stage Renal FailureBone Marrow TransplantationEventEngraftmentChimerismCyclophosphamideFamily MemberCohortAllogenicConditioningGraft RejectionClinical RemissionChronic Graft Versus Host DiseaseBone Marrow PurgingBeta ThalassemiaCirrhosis
Grant awards (13)
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$3,067,391
ZIA · FY2025 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$3,354,118
ZIA · FY2024 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$1,902,764
ZIA · FY2022 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$1,828,956
ZIA · FY2021 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$1,032,508
ZIA · FY2020 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$1,189,478
ZIA · FY2019 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$1,921,353
ZIA · FY2018 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$1,376,420
ZIA · FY2017 · HL · contact PI
Optimization of Fetal Hemoglobin Production to Prevent or Reverse Organ Damage and Improve Survival in Patients with Sickle Cell Disease$71,164
ZIA · FY2017 · HL · contact PI
Optimization of Fetal Hemoglobin Production to Prevent or Reverse Organ Damage and Improve Survival in Patients with Sickle Cell Disease$2,646,917
ZIA · FY2016 · HL · contact PI
Nonmyeloablative haploidentical peripheral blood stem cell transplantation in congenital anemias$882,306
ZIA · FY2016 · HL · contact PI
Optimization of Fetal Hemoglobin Production to Prevent or Reverse Organ Damage and Improve Survival in Patients with Sickle Cell Disease$3,298,666
ZIA · FY2015 · HL · contact PI
Optimization of Fetal Hemoglobin Production to Prevent or Reverse Organ Damage and Improve Survival in Patients with Sickle Cell Disease$541,648
ZIA · FY2014 · HL · contact PI